Clinical Trial Update: Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed concurrent radiotherapy with cisplatin given every three weeks for advanced cervical cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Korea Cancer Center Hospital | Conditions: CERVICAL NEOPLASMS | Phase 2 | Status: COMPLETED